Sugarcane is the world's largest crop by biomass yield, providing 80% of the sugar and 40% of the biofuel produced worldwide. The plant's size and efficient use of water and light make it a prime candidate to produce advanced ...
A team from the Innovative Genomics Institute at the University of California, Berkeley (UCB) has produced an increase in gene expression in a food crop by changing its upstream regulatory DNA. While other studies have used ...
During her chemistry Nobel Prize lecture in 2018, Frances Arnold said, "Today we can for all practical purposes read, write and edit any sequence of DNA, but we cannot compose it." That isn't true anymore.
Recent research has uncovered the genetic mechanisms behind sea lavender's (Limonium bicolor) salt tolerance by studying basic helix–loop–helix (bHLH) transcription factors. Identifying 187 bHLH genes, the study highlights ...
Researchers have developed a novel version of a key CRISPR gene-editing protein that shows efficient editing activity and is small enough to be packaged within a non-pathogenic virus that can deliver it to target cells. Hongjian ...
CRISPR/Cas9 remains the most powerful tool to generate mutations in plant genomes. Studying the various combinations of mutations has significantly increased the scale of experimental setups, necessitating more space to grow ...
Traditional genome editing techniques encounter significant challenges in vegetatively propagated crops like grapes. Current transformation methods exhibit low efficiency and face difficulties in achieving stable plant regeneration ...
CRISPR-Cas systems have revolutionized biotechnology by offering ways to edit genes like a pair of programmable scissors. In nature, bacteria use these systems to fight off deadly viruses. A recent international collaboration ...
Vibrio parahaemolyticus is a Gram-negative, halophilic bacterium prevalent in marine environments and is the primary cause of acute hepatopancreatic necrosis, also known as early death syndrome, in aquaculture.
A simple and robust strategy developed by KAUST scientists could help to improve the safety and accuracy of CRISPR gene editing, a tool that is already approved for clinical use for the treatment of inherited blood disorders.
